日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up Time

肿瘤时间进程可预测接受阿特珠单抗治疗的非小细胞肺癌患者的总生存期:取决于随访时间

Netterberg, Ida; Bruno, René; Chen, Ya-Chi; Winter, Helen; Li, Chi-Chung; Jin, Jin Y; Friberg, Lena E

A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab-Treated non-small Cell Lung Cancer Patients

阿特珠单抗治疗的非小细胞肺癌患者循环生物标志物的药代动力学/药效学分析及其与肿瘤反应的关系

Netterberg, Ida; Li, Chi-Chung; Molinero, Luciana; Budha, Nageshwar; Sukumaran, Siddharth; Stroh, Mark; Jonsson, E Niclas; Friberg, Lena E

The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling

通过模型分析白细胞介素-6和C反应蛋白的时间进程,可以预测乳腺癌患者辅助化疗后发生发热性中性粒细胞减少症的风险。

Netterberg, Ida; Karlsson, Mats O; Nielsen, Elisabet I; Quartino, Angelica L; Lindman, Henrik; Friberg, Lena E

Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring

基于频繁中性粒细胞监测的骨髓抑制和恢复的模型预测

Netterberg, Ida; Nielsen, Elisabet I; Friberg, Lena E; Karlsson, Mats O

Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4

胆汁淤积性药物性肝损伤的危险因素:抑制肝脏基底侧胆汁酸转运体多药耐药相关蛋白 3 和 4

Kathleen Köck, Brian C Ferslew, Ida Netterberg, Kyunghee Yang, Thomas J Urban, Peter W Swaan, Paul W Stewart, Kim L R Brouwer